Mersana Therapeutics, Inc.

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Timothy B Lowinger. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Timothy B Lowinger har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:MRSN / Mersana Therapeutics, Inc. SVP, Chief Sci.&Tech. Officer 257.673
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Timothy B Lowinger. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb MRSN / Mersana Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i MRSN / Mersana Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MRSN / Mersana Therapeutics, Inc. Insider Trades
Insidersalg MRSN / Mersana Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i MRSN / Mersana Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-01-17 MRSN Lowinger Timothy B 6.233 5,7400 249 143,5000 35.777 197 1.0600 -35.513 -99,26
2022-01-18 MRSN Lowinger Timothy B 4.741 5,9200 190 148,0000 28.067
2021-07-19 MRSN Lowinger Timothy B 8.496 12,0200 340 300,5000 102.122
2021-07-16 MRSN Lowinger Timothy B 7.775 12,4700 311 311,7500 96.954

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

MRSN / Mersana Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Timothy B Lowinger som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-01-17 2025-01-16 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -8.048 257.673 -3,03 0,58 -4.668 149.450
2025-01-17 2025-01-15 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 12.500 265.721 4,94
2025-01-17 2025-01-15 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 7.291 253.221 2,96
2025-01-16 2025-01-15 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.794 245.930 -0,72 0,63 -1.130 154.936
2025-01-16 2025-01-14 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 4.792 247.724 1,97
2025-01-15 2025-01-14 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -3.483 242.932 -1,41 0,66 -2.299 160.335
2025-01-15 2025-01-13 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 9.375 246.415 3,96
2024-10-07 2024-10-03 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -5.598 235.642 -2,32 1,96 -10.972 461.858
2024-10-07 2024-10-02 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -8.089 241.240 -3,24 2,00 -16.178 482.480
2024-10-07 2024-10-01 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 50.000 249.329 25,08
2024-01-17 2024-01-16 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -10.409 199.329 -4,96 2,71 -28.208 540.182
2024-01-17 2024-01-15 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 7.916 209.738 3,92
2024-01-17 2024-01-15 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 7.292 201.822 3,75
2024-01-17 2024-01-14 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 4.792 194.530 2,53
2024-01-17 2024-01-13 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 9.375 189.738 5,20
2023-01-18 2023-01-17 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale -6.233 180.363 -3,34 5,74 -35.777 1.035.284
2023-01-18 2023-01-15 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 7.917 186.596 4,43
2023-01-18 2023-01-15 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 7.292 178.679 4,25
2023-01-18 2023-01-14 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 4.792 171.387 2,88
2022-12-16 2022-12-14 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 24.250 166.595 17,04 1,53 37.102 254.890
2022-12-16 2022-12-14 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 11.111 142.345 8,47 1,40 15.555 199.283
2022-01-19 2022-01-18 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale -4.741 131.234 -3,49 5,92 -28.067 776.905
2022-01-19 2022-01-14 4 MRSN Mersana Therapeutics, Inc.
Restricted Stock Units
A - Award 19.167 19.167
2022-01-19 2022-01-14 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
A - Award 86.250 86.250
2022-01-19 2022-01-14 4 MRSN Mersana Therapeutics, Inc.
Restricted Stock Units
M - Exercise -7.292 21.875 -25,00
2022-01-19 2022-01-14 4 MRSN Mersana Therapeutics, Inc.
Restricted Stock Units
M - Exercise -7.917 15.833 -33,33
2022-01-19 2022-01-14 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 15.209 135.975 12,59
2021-12-20 2021-12-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -45.593 0 -100,00
2021-12-20 2021-12-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 45.593 120.766 60,65 1,40 63.830 169.072
2021-08-24 2021-08-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.216 77.195 -2,79
2021-08-24 2021-08-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.216 75.173 -2,86 11,01 -24.398 827.655
2021-08-24 2021-08-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.216 77.389 2,95 6,16 13.651 476.716
2021-07-22 2021-07-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 79.411 -2,73
2021-07-22 2021-07-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 75.173 -2,88 12,11 -26.969 910.345
2021-07-22 2021-07-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 77.400 2,96 6,16 13.718 476.784
2021-07-19 2021-07-19 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale -8.496 75.173 -10,15 12,02 -102.122 903.579
2021-07-19 2021-07-16 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale -7.775 83.669 -8,50 12,47 -96.954 1.043.352
2021-07-19 2021-07-15 4 MRSN Mersana Therapeutics, Inc.
Restricted Stock Units
M - Exercise -40.000 0 -100,00
2021-07-19 2021-07-15 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 40.000 91.444 77,75
2021-07-09 2021-07-08 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -20.000 45.593 -30,49
2021-07-09 2021-07-08 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 20.000 51.444 63,61 1,40 28.000 72.022
2021-07-02 2021-07-01 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -9 81.638 -0,01
2021-07-02 2021-07-01 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.877 10.303 -15,41
2021-07-02 2021-07-01 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.886 31.444 -5,66 13,60 -25.650 427.638
2021-07-02 2021-07-01 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 9 33.330 0,03 6,16 55 205.313
2021-07-02 2021-07-01 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.877 33.321 5,97 3,51 6.588 116.957
2021-06-23 2021-06-21 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.218 81.647 -2,64
2021-06-23 2021-06-21 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2 12.180 -0,02
2021-06-23 2021-06-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.218 31.444 -6,59 13,78 -30.564 433.298
2021-06-23 2021-06-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.218 33.662 7,05 6,16 13.663 207.358
2021-06-23 2021-06-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2 31.444 -0,01 13,78 -28 433.298
2021-06-23 2021-06-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2 31.446 0,01 3,51 7 110.375
2021-05-24 2021-05-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 83.865 -2,59
2021-05-24 2021-05-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.875 12.182 -13,34
2021-05-24 2021-05-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 31.444 -6,61 14,10 -31.401 443.360
2021-05-24 2021-05-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 33.671 7,08 6,16 13.718 207.413
2021-05-24 2021-05-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.875 31.444 -5,63 14,10 -26.438 443.360
2021-05-24 2021-05-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.875 33.319 5,96 3,51 6.581 116.950
2021-04-22 2021-04-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 86.092 -2,52
2021-04-22 2021-04-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.875 14.057 -11,77
2021-04-22 2021-04-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 31.444 -6,61 15,91 -35.432 500.274
2021-04-22 2021-04-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 33.671 7,08 6,16 13.718 207.413
2021-04-22 2021-04-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.875 31.444 -5,63 15,91 -29.831 500.274
2021-04-22 2021-04-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.875 33.319 5,96 3,51 6.581 116.950
2021-03-24 2021-03-22 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 88.319 -2,46
2021-03-24 2021-03-22 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 88.319 -2,46
2021-03-24 2021-03-22 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.875 15.932 -10,53
2021-03-24 2021-03-22 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.874 17.807 -9,52
2021-03-24 2021-03-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 31.444 -6,61 17,50 -38.972 550.270
2021-03-24 2021-03-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 31.444 -6,61 17,50 -38.972 550.270
2021-03-24 2021-03-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 33.671 7,08 6,16 13.718 207.413
2021-03-24 2021-03-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 33.671 7,08 6,16 13.718 207.413
2021-03-24 2021-03-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.875 31.444 -5,63 17,50 -32.812 550.270
2021-03-24 2021-03-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.875 33.319 5,96 3,51 6.581 116.950
2021-03-24 2021-03-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.874 31.444 -5,62 17,50 -32.795 550.270
2021-03-24 2021-03-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.874 33.318 5,96 3,51 6.578 116.946
2021-02-24 2021-02-22 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 92.773 -2,34
2021-02-24 2021-02-22 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 92.773 -2,34
2021-02-24 2021-02-22 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.875 19.681 -8,70
2021-02-24 2021-02-22 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.874 21.556 -8,00
2021-02-24 2021-02-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 31.444 -6,61 20,01 -44.562 629.194
2021-02-24 2021-02-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 31.444 -6,61 20,01 -44.562 629.194
2021-02-24 2021-02-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 33.671 7,08 6,16 13.718 207.413
2021-02-24 2021-02-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 33.671 7,08 6,16 13.718 207.413
2021-02-24 2021-02-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.875 31.444 -5,63 20,01 -37.519 629.194
2021-02-24 2021-02-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.875 33.319 5,96 3,51 6.581 116.950
2021-02-24 2021-02-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.874 31.444 -5,62 20,01 -37.499 629.194
2021-02-24 2021-02-22 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.874 33.318 5,96 3,51 6.578 116.946
2021-01-22 2021-01-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 97.227 -2,24
2021-01-22 2021-01-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 97.227 -2,24
2021-01-22 2021-01-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.875 23.430 -7,41
2021-01-22 2021-01-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.874 25.305 -6,90
2021-01-22 2021-01-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 31.444 -6,61 21,54 -47.970 677.304
2021-01-22 2021-01-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 31.444 -6,61 21,54 -47.970 677.304
2021-01-22 2021-01-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 33.671 7,08 6,16 13.718 207.413
2021-01-22 2021-01-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 33.671 7,08 6,16 13.718 207.413
2021-01-22 2021-01-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.875 31.444 -5,63 21,54 -40.388 677.304
2021-01-22 2021-01-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.875 33.319 5,96 3,51 6.581 116.950
2021-01-22 2021-01-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.874 31.444 -5,62 21,54 -40.366 677.304
2021-01-22 2021-01-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.874 33.318 5,96 3,51 6.578 116.946
2021-01-20 2021-01-15 4 MRSN Mersana Therapeutics, Inc.
Restricted Stock Units
A - Award 29.167 29.167
2021-01-20 2021-01-15 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
A - Award 131.250 131.250
2021-01-20 2021-01-15 4 MRSN Mersana Therapeutics, Inc.
Restricted Stock Units
M - Exercise -7.917 23.750 -25,00
2021-01-20 2021-01-15 4 MRSN Mersana Therapeutics, Inc.
Common Stock
F - Taxes -2.324 31.444 -6,88 21,09 -49.013 663.154
2021-01-20 2021-01-15 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 7.917 33.768 30,63
2020-12-30 2020-12-28 4 [MRSN] Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -9.000 65.593 -12,07
2020-12-30 2020-12-28 4 [MRSN] Mersana Therapeutics, Inc.
Common Stock
M - Exercise 9.000 25.851 53,41 1,40 12.600 36.191
2020-12-22 2020-12-21 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 101.681 -2,14
2020-12-22 2020-12-21 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 101.681 -2,14
2020-12-22 2020-12-21 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.875 27.179 -6,45
2020-12-22 2020-12-21 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.874 29.054 -6,06
2020-12-22 2020-12-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 0 -100,00 25,60 -57.011
2020-12-22 2020-12-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 2.227 6,16 13.718 13.718
2020-12-22 2020-12-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 2.227 6,16 13.718 13.718
2020-12-22 2020-12-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.875 0 -100,00 25,60 -48.000
2020-12-22 2020-12-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.875 1.875 3,51 6.581 6.581
2020-12-22 2020-12-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 0 -100,00 25,59 -56.989
2020-12-22 2020-12-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.874 0 -100,00 25,59 -47.956
2020-12-22 2020-12-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.874 1.874 3,51 6.578 6.578
2020-11-24 2020-11-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 106.135 -2,06
2020-11-24 2020-11-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 106.135 -2,06
2020-11-24 2020-11-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.875 30.928 -5,72
2020-11-24 2020-11-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.874 32.803 -5,40
2020-11-24 2020-11-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 0 -100,00 23,04 -51.310
2020-11-24 2020-11-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 2.227 6,16 13.718 13.718
2020-11-24 2020-11-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 2.227 6,16 13.718 13.718
2020-11-24 2020-11-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.875 0 -100,00 23,04 -43.200
2020-11-24 2020-11-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.875 1.875 3,51 6.581 6.581
2020-11-24 2020-11-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 0 -100,00 23,06 -51.355
2020-11-24 2020-11-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.874 0 -100,00 23,06 -43.214
2020-11-24 2020-11-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.874 1.874 3,51 6.578 6.578
2020-10-22 2020-10-21 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 110.589 -1,97
2020-10-22 2020-10-21 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.874 34.677 -5,13
2020-10-22 2020-10-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 16.851 -11,67 17,50 -38.972 294.892
2020-10-22 2020-10-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 19.078 13,22 6,16 13.718 117.520
2020-10-22 2020-10-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.874 16.851 -10,01 17,50 -32.795 294.892
2020-10-22 2020-10-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.874 18.725 11,12 3,51 6.578 65.725
2020-10-22 2020-10-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -15.240 74.593 -16,96
2020-10-22 2020-10-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise -1.611 0 -100,00
2020-10-22 2020-10-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -2.227 112.816 -1,94
2020-10-22 2020-10-20 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -1.875 36.551 -4,88
2020-10-22 2020-10-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 15.240 16.851 946,00 1,40 21.336 23.591
2020-10-22 2020-10-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 1.611 1.611 7,43 11.970 11.970
2020-10-22 2020-10-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -2.227 0 -100,00 16,74 -37.280
2020-10-22 2020-10-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 2.227 2.227 6,16 13.718 13.718
2020-10-22 2020-10-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -1.875 0 -100,00 16,74 -31.388
2020-10-22 2020-10-20 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 1.875 1.875 3,51 6.581 6.581
2020-09-23 2020-09-21 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -4.454 115.043 -3,73
2020-09-23 2020-09-21 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
M - Exercise X -3.749 38.426 -8,89
2020-09-23 2020-09-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -12.411 0 -100,00 20,66 -256.379
2020-09-23 2020-09-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -4.454 12.411 -26,41 20,66 -92.008 256.379
2020-09-23 2020-09-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 4.454 16.865 35,89 6,16 27.437 103.888
2020-09-23 2020-09-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -3.749 12.411 -23,20 20,66 -77.445 256.379
2020-09-23 2020-09-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise X 3.749 16.160 30,21 3,51 13.159 56.722
2020-01-16 2020-01-15 4 MRSN Mersana Therapeutics, Inc.
Restricted Stock Units
A - Award 31.667 31.667
2020-01-16 2020-01-15 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
A - Award 142.500 142.500
2019-07-19 2019-07-17 4 MRSN Mersana Therapeutics, Inc.
Restricted Stock Units
A - Award 40.000 40.000
2019-01-25 2019-01-23 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
A - Award 60.000 60.000
2018-09-25 2018-09-24 4 MRSN Mersana Therapeutics, Inc.
Option to purchase Common Stock
M - Exercise -3.500 89.833 -3,75
2018-09-25 2018-09-24 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -3.500 12.491 -21,89 11,63 -40.705 145.270
2018-09-25 2018-09-24 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 3.500 15.991 28,02 1,40 4.900 22.387
2018-08-29 2018-08-27 4 MRSN Mersana Therapeutics, Inc.
Option to purchase Common Stock
M - Exercise -3.500 1.611 -68,48
2018-08-29 2018-08-27 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -3.500 12.491 -21,89 13,15 -46.025 164.257
2018-08-29 2018-08-27 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 3.500 15.991 28,02 7,43 26.005 118.813
2018-07-25 2018-07-23 4 MRSN Mersana Therapeutics, Inc.
Common Stock
S - Sale X -3.500 12.491 -21,89 11,06 -38.710 138.150
2018-07-05 2018-07-03 4 MRSN Mersana Therapeutics, Inc.
Option to Purchase Common Stock
M - Exercise -10.000 93.333 -9,68
2018-07-05 2018-07-03 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 10.000 15.991 166,92 1,40 14.000 22.387
2018-02-23 2018-02-21 4 MRSN Mersana Therapeutics, Inc.
Option to Purchase Common Stock
M - Exercise -5.911 0 -100,00
2018-02-23 2018-02-21 4 MRSN Mersana Therapeutics, Inc.
Common Stock
M - Exercise 5.911 5.911 6,98 41.259 41.259
2018-02-06 2018-02-02 4 MRSN Mersana Therapeutics, Inc.
Stock Option (right to buy)
A - Award 56.884 56.884
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)